lactic acid has been researched along with 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, K; Ikeda, G; Ishikita, A; Koga, J; Mao, Y; Matoba, T; Nakano, K; Sadoshima, J; Takeuchi, O | 1 |
1 other study(ies) available for lactic acid and 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone
| Article | Year |
|---|---|
Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial
Topics: Animals; bcl-2-Associated X Protein; Biocompatible Materials; Cell Survival; Cytochromes c; Drug Carriers; Drug Delivery Systems; Dynamins; Heart; Hydrogen Peroxide; Isolated Heart Preparation; Lactic Acid; Mice; Mitochondrial Membranes; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nanoparticles; Oxidants; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Transport; Quinazolinones; Rats | 2016 |